Suchergebnisse - "Rosenberg, J E"

PubPharm (29)

1

EV-301 long-term outcomes : 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Rosenberg, J. | Powles, T. | Sonpavde, G. | +11

2

Utility of Routine Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography in Identifying Pathological Lymph Node Metastases at Radical Cystectomy. Reply

enthalten in: The Journal of urology | 2021

von Dason, S. | Wong, N. | Donahue, T. | +12

CommentOn: J Urol. 2021 Jul;206(1):169-170. - PMID 33793307

3

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees†

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Horwich, A. | Babjuk, M. | Bellmunt, J. | +98

4

Novel therapies in urothelial carcinoma : a biomarker-driven approach

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Iyer, G. | Rosenberg, J.

5

Commentary on "DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma."

enthalten in: Urologic oncology | 2018

von Teo, M. | Bambury, R. | Zabor, E. | +17

CommentOn: Clin Cancer Res. 2017 Jul 15;23(14):3610-3618. - PMID 28137924

6

Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma : post-progression outcomes from the phase II IMvigor210 study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Necchi, A. | Joseph, R. | Loriot, Y. | +9

7

Nivolumab monotherapy in metastatic urothelial cancer (mUC): Updated efficacy by subgroups and safety results from the CheckMate 032 study

enthalten in: Annals of oncology | 2016

von Rosenberg, J. | Bono, P. | Kim, J. | +14

8

Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma : implications for trial design

enthalten in: Clinical genitourinary cancer | 2015

von Pond, G. | Bellmunt, J. | Rosenberg, J. | +15

9

Deleterious Alterations in DNA Damage Response Genes Are Associated With Improved Outcome in Muscle-Invasive Bladder Cancer Patients Treated With Radiation-Based Bladder Preservation

enthalten in: International journal of radiation oncology, biology, physics | 2015

von Iyer, G. | Bajorin, D. | Berger, M. | +11

10

Image-Guided Intensity Modulated Radiation Therapy (IMRT) for Bladder Cancer: Toxicity and Early Outcomes

enthalten in: International journal of radiation oncology, biology, physics | 2014

von Kollmeier, M. | Thakker, N. | Zelefsky, M. | +4